Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Feb;126(3):402-411.
doi: 10.1111/1471-0528.15471. Epub 2018 Oct 23.

Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial

Cmg van Driel  1   2 , G H de Bock  2 , M J Schroevers  3 , M J Mourits  1
Affiliations
Randomized Controlled Trial

Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial

Cmg van Driel et al. BJOG. 2019 Feb.

Abstract

Objective: To assess the short- and long-term effects of mindfulness-based stress reduction (MBSR) on the resulting quality of life, sexual functioning, and sexual distress after risk-reducing salpingo-oophorectomy (RRSO).

Design: Randomised controlled trial.

Setting: A specialised family cancer clinic of the university medical center Groningen.

Population: Sixty-six women carriers of the BRCA1/2 mutation who developed at least two moderate-to-severe menopausal symptoms after RRSO.

Methods: Women were randomised to an 8-week MBSR training programme or to care as usual (CAU).

Main outcome measures: Change in the Menopause-Specific Quality of Life Questionnaire (MENQOL), the Female Sexual Function Index, and the Female Sexual Distress Scale, administered from baseline at 3, 6, and 12 months. Linear mixed modelling was applied to compare the effect of MBSR with CAU over time.

Results: At 3 and 12 months, there were statistically significant improvements in the MENQOL for the MBSR group compared with the CAU group (both P = 0.04). At 3 months, the mean MENQOL scores were 3.5 (95% confidence interval, 95% CI 3.0-3.9) and 3.8 (95% CI 3.3-4.2) for the MBSR and CAU groups, respectively; at 12 months, the corresponding values were 3.6 (95% CI 3.1-4.0) and 3.9 (95% CI 3.5-4.4). No significant differences were found between the MBSR and CAU groups in the other scores.

Conclusion: Mindfulness-based stress reduction was effective at improving quality of life in the short- and long-term for patients with menopausal symptoms after RRSO; however, it was not associated with an improvement in sexual functioning or distress.

Tweetable abstract: Mindfulness improves menopause-related quality of life in women after risk-reducing salpingo-oophorectomy.

Keywords: BRCA1/2; menopausal symptoms; mindfulness; salpingo-oophorectomy; sexual functioning; surgical menopause.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Population flowchart. *A total of 39 women responded that they had no interest in participating in the study without filling in the rest of the questionnaire. #The T0, T1, T2, and T3 questionnaires were sent out at 0, 3, 6, and 12 months after randomisation, respectively.
Figure 2
Figure 2
MENQOL score estimates per time point and treatment arm. The error bars represent standard errors.
See this image and copyright information in PMC

References

    1. Antoniou A, Pharoah PDP, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117–30. - PMC - PubMed
    1. Chen X, Guo T, Li B. Influence of prophylactic oophorectomy on mood and sexual function in women of menopausal transition or postmenopausal period. Arch Gynecol Obstet 2013;288:1101–6. - PubMed
    1. van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJE, de Vries J, et al. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat 2010;124:643–51. - PubMed
    1. Brohet RM, Velthuizen ME, Hogervorst FBL, Meijers‐Heijboer HEJ, Seynaeve C, Collée MJ, et al. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 2014;51:98–107. - PubMed
    1. Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG. Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective. BJOG 2007;114:1500–9. - PubMed

Publication types

MeSH terms